Introduction {#sec1}
============

First identified in yeast ([@bib33; @bib65]), the core Mediator complex consists of three distinct modules (Head, Middle, and Tail), with a fourth Kinase module present in some cases. Mediator physically links enhancer bound regulatory factors to RNA polymerase II (Pol II) through context-specific interactions with its Tail and Head subunits, respectively ([@bib20; @bib34; @bib65]). Work in yeast suggesting that Mediator is present at the promoters of nearly all protein coding genes and is required for both basal and activator-mediated transcription ([@bib24; @bib64]) has led to the view that Mediator is part of the general transcription machinery; however, analysis of several Mediator mutants in plants and animals has not supported this model. Specific subunits have been shown to control only a subset of target genes that in turn affect specific developmental or organ-specific processes (reviewed in [@bib21]). The multitude of interactions documented for the 31 subunits of the Mediator complex delineate its vast functional versatility and has led to the more recent view of Mediator as an integrative hub of transcriptional regulation.

Development at a cellular level involves progression along a continuum from complete plasticity to terminal differentiation. For most cells, cell fate becomes "locked in" as development proceeds ([@bib23; @bib47]). Stem and progenitor cells are capable of halting their progression along this developmental path and act as reserves for tissue homeostasis and regeneration. Much of what is known on how cells maintain their "stemness" has come from studying cultured embryonic stem cells (ESCs), which has revealed a complex network of transcription factors that act in concert to maintain pluripotency ([@bib46; @bib60]). Intriguingly, an RNAi screen for key regulators of pluripotency maintenance in mouse ESCs ([@bib30]) uncovered 12 subunits of Mediator, with the strongest effect resulting from knockdown of Med14. Med12 has additionally been shown to act together with Nanog to regulate a stem cell gene signature in mouse ESCs ([@bib68]). Whether the role of Mediator function in ESC maintenance extends generally to in vivo stem cell populations remains largely unknown.

In this study, we found that while zebrafish *med14* mutant embryos were largely arrested in development, there was a surprisingly limited effect on overall transcription. Transplantation experiments demonstrated that Med14 function is largely dispensable for cell survival into adulthood. Loss of *med14*, as well as several other Mediator components, in the planarian *Schmidtea mediterranea* resulted in severe stem cell and regeneration defects, with transcription in other tissues apparently unaffected. Examination of *med14* mutant zebrafish embryos also suggested a function in stem cell maintenance and regeneration. Taken together, our results show that Med14 has a conserved function in the maintenance of both embryonic and adult stem cell populations and suggest a broader in vivo role for Mediator in stem cell maintenance.

Results {#sec2}
=======

Zebrafish *logelei* Mutants Have a Pleiotropic Phenotype Suggestive of Developmental Arrest {#sec2.1}
-------------------------------------------------------------------------------------------

A novel (*s231*) allele of the *logelei* (*log*) mutant was previously isolated in a screen for mutations affecting cardiovascular development ([@bib28]). At 1-day post-fertilization (dpf), *log* mutant hearts appeared completely normal ([Figure 1](#fig1){ref-type="fig"}A). Cardiac defects first became apparent in *log* mutants by 2 dpf, with a failure of heart looping ([Figures 1](#fig1){ref-type="fig"}B and 1C). By RNA in situ hybridization (ISH), expression of the chamber-specific markers *myh6*/*amhc* (atrium) and *vmhc* (ventricle) was normal in *log* mutants ([Figures 1](#fig1){ref-type="fig"}D--1I). The first observable *log* phenotype, a defect in brain ventricle inflation ([@bib56]), was apparent by 36-hr post-fertilization (hpf). Following this, a developmental delay became apparent in *log* mutants from 48--96 hpf, including absence of pectoral fin elongation and semi-circular canals of the otic vesicle ([Figures 1](#fig1){ref-type="fig"}J--1M, arrowheads). Head-trunk angle, a measure of developmental progression ([@bib35]), was largely fixed in *log* mutants by 48 hpf ([Figure 1](#fig1){ref-type="fig"}N). Despite this arrest in development, there was not an apparent increase in apoptosis or overt proliferative defect ([Figure S1](#app3){ref-type="sec"}).

*logelei* Is due to Mutation of *med14* {#sec2.2}
---------------------------------------

We next sought to determine the causal *log* mutation, which we had previously localized to linkage group 9 ([@bib28]). Further mapping defined a zero recombination region of approximately 100 kb containing four genes. RT-PCR and sequencing from mutant (*s231* and the previously isolated *m628* and *m673* alleles) and wild-type (WT) cDNA pools identified distinct premature stop codons in *med14* in all three alleles ([Figure 2](#fig2){ref-type="fig"}A). Injection of *med14* morpholino recapitulated otic vesicle, pectoral fin and cardiac phenotypes, while injection of 300 pg of RNA encoding a WT form of Med14 partially rescued these defects in *log* mutants ([Figures 2](#fig2){ref-type="fig"}B--2E′′′). Further, injection of RNA encoding the *s231*, *m628*, and *m673* forms of *med14* failed to affect appreciable rescue of *log* mutants (results not shown). Taken together, this established that the *log* phenotype is due to mutation of *med14*.

Maternal Expression of *med14* Affects Timing of Phenotypic Onset {#sec2.3}
-----------------------------------------------------------------

As we expected that loss of Med14 would have global effects on transcription, we next examined whether *med14* had a maternal function. Injection of *med14* morpholino (which would affect maternal *med14* transcript, but not protein) worsened the *log* mutant phenotype ([Figure 3](#fig3){ref-type="fig"}A), notably inducing defects in skeletal muscle fibers ([Figures 3](#fig3){ref-type="fig"}A′ and 3A′′). *med14* transcript was maternally deposited ([Figure 3](#fig3){ref-type="fig"}B) and expressed broadly later in development ([Figure 3](#fig3){ref-type="fig"}C; data not shown). ISH analysis in *m628* allele mutants revealed a loss of *med14* expression by 24hpf, suggesting nonsense-mediated decay of mutant transcript and degradation of maternally deposited WT transcript by this time point ([Figure 3](#fig3){ref-type="fig"}D). Efforts to deplete WT maternal *med14* transcript by making maternal zygotic mutants through a germline replacement strategy ([@bib10]) were not successful (results not shown). To determine whether the *log* mutant phenotype could be alleviated by prolonged expression of *med14*, we generated a transgenic line expressing WT *med14* RNA under control of the inducible *hsp70* promoter, which had no apparent effects on WT development ([Figure 3](#fig3){ref-type="fig"}E). In *log* mutants, overexpression of *med14* every 12 hr beginning at 12 hpf until 120 hpf resulted in maximal rescue ([Figure 3](#fig3){ref-type="fig"}F). Further analysis revealed that initiation of *med14* overexpression at 24 hpf or later in *log* mutants resulted in progressively more severe phenotypes, with initiation after 48 hpf resulting in no discernable rescue ([Figures 3](#fig3){ref-type="fig"}G--3K). These results suggest that maternal Med14 function alleviates the severity of early phenotypes in *log* mutants.

Transcription Is Not Broadly Affected in *log* Mutants {#sec2.4}
------------------------------------------------------

To examine effects on Pol II transcription in *log* mutants, we first assayed expression of *opsin1sw1*, which is initiated in the eye at 2.5 dpf, after developmental defects are readily apparent ([Figures 4](#fig4){ref-type="fig"}A and 4B). Although delayed in *log* mutants (data not shown), *opsin1sw1* expression reached a level comparable to WT by 4.0 dpf ([Figures 4](#fig4){ref-type="fig"}C and 4D). To test whether transcription could be induced in *log* mutants, we heat shocked *log* mutant *hsp70:EGFP* embryos at 3.5 dpf, after which a robust EGFP fluorescence was observable at 4.0 dpf ([Figure 4](#fig4){ref-type="fig"}E). To examine whether cellular transcription and function could continue in the prolonged absence of Med14 function, we carried out transplantation experiments to place transgenic (constitutive *β-actin:EGFP*) *log* mutant cells in WT host embryos, thus circumventing the issue of embryonic lethality. *β-actin:EGFP* expression in *log* mutant cells was evident at 15 dpf ([Figure 4](#fig4){ref-type="fig"}F, mutant cells seen in 100% of 50 transplants). Interestingly, cells were found to contribute to structures not present in mutant embryos, such as the semicircular canals. In fish aged up to 2 years, EGFP-+'ve *log* mutant cells persisted, as was evident in many nonpigmented tissues ([Figures 4](#fig4){ref-type="fig"}G--4H′). This clearly demonstrated that Med14 was not (at least cell autonomously) required for constitutive transcription or cell survival.

To address in a quantitative manner the extent transcription may be globally affected in *log* mutants, we undertook a microarray approach to analyze genome-wide transcript levels at 2.25 dpf (when the *log* mutant phenotype is apparent). Surprisingly, in *log* mutants, only ∼2% of genes assayed were differentially expressed (764 of 34,858 with ≥2-fold difference), with a roughly equal number of genes being upregulated or downregulated ([Figure 4](#fig4){ref-type="fig"}I). To dismiss the possibility that transcription levels were reduced globally in *log* mutants ([@bib41]), we assayed mRNA (poly A) levels from an equivalent amounts of total RNA; however, no difference was evident even at 3.25 dpf ([Figure 4](#fig4){ref-type="fig"}J). RNA and DNA spike-ins and genomic PCR to normalize data to total genomic content (cell number) ([@bib7]) was further used to stringently assay mean levels of gene expression. However, global changes in Pol II gene expression were not evident in *med14* mutants ([Figure 4](#fig4){ref-type="fig"}L). qRT-PCR analysis validated that from 1.5-3.25 dpf *med14* transcript levels were significantly downregulated in *log* mutants, in line with our RNA ISH analysis ([Figure 4](#fig4){ref-type="fig"}L).

*med14* Is Necessary for Stem Cell Maintenance in Planarians {#sec2.5}
------------------------------------------------------------

To further decipher Med14 function, we pursued *med14* knockdown in the freshwater planarian *S. mediterranea*. A BLAST search of *S. mediterranea* genome and transcriptomes ([@bib37]) with both human and zebrafish Med14 sequences revealed a single planarian ortholog, *Smed-med14* (*med14* in this manuscript). When intact planarians were subjected to *med14* RNAi, 100% of animals displayed a ventral curling phenotype by 10 days after the third feeding (3fd10) ([Figures 5](#fig5){ref-type="fig"}A--5D). By 3fd15, head and tail regression phenotypes became pronounced in *med14(RNAi)* animals ([Figures 5](#fig5){ref-type="fig"}E and 5F), with lysis of the epidermis following ([Figure 5](#fig5){ref-type="fig"}G), similar to what is observed following irradiation ([Figure 5](#fig5){ref-type="fig"}H). As ventral curling and lysis are hallmarks of a stem cell defect ([@bib52]), we next examined whether *med14(RNAi)* animals retained regenerative ability, which depends on stem cell function. Following amputation into thirds at 3fd3, regeneration was severely diminished at both 3 and 7 days post-amputation (dpa) in *med14(RNAi)* animals ([Figures 5](#fig5){ref-type="fig"}I--5L). As seen in zebrafish embryos, *med14* appeared to be ubiquitously expressed in planarians ([Figure 6](#fig6){ref-type="fig"}A). However, dilution of probe and reduction of staining time resulted in a stem cell-like expression pattern ([Figure 6](#fig6){ref-type="fig"}A′), in agreement with transcriptome data showing *med14* to be 6.7-fold enriched in stem cells over differentiated tissues ([@bib37]). Confirmation of *med14* expression in (but not limited to) stem cells was obtained by confocal imaging of the head and tail regions following *med14* fluorescent RNA ISH and PIWI (a marker of stem cells) antibody staining ([Figures 6](#fig6){ref-type="fig"}A′′ and 6A′′′).

To further examine the *med14(RNAi)* phenotype, RNA ISH was carried out for markers of the stem, progeny, and somatic compartments of the animal. Analysis of the stem cell marker *piwi-1* ([@bib52]) revealed a reduction in *piwi-1*-expressing cells in *med14(RNAi)* worms by 3fd6 and a complete absence by 3fd12 ([Figures 6](#fig6){ref-type="fig"}B--6C′′′). However, expression of *piwi-1* could still be detected in two dorsal-lateral regions that may represent primordial germ cells ([@bib70]) ([Figure 6](#fig6){ref-type="fig"}C′′′, red arrowheads), suggesting that Med14 is not required directly for *piwi-1* expression. As the stem cell compartment in planaria is the only one that undergoes proliferation ([@bib51]), expression of markers of mitosis (phosphorylated histone H3-H3P) and S-phase (*h2b* and *pcna*) was assayed. As expected for a complete stem cell loss, proliferation was not evident in *med14(RNAi)* animals by 3fd9/12 ([Figures 6](#fig6){ref-type="fig"}D--6I). The loss of *piwi-1*-expressing cells following *med14* RNAi may have been as a consequence of differentiation of the stem cell compartment. To examine this, we analyzed the expression of *prog-1*, which marks the immediate daughters of stem cells ([@bib17]), in control and *med14(RNAi)* worms ([Figures 6](#fig6){ref-type="fig"}J--6K′). A reduction to complete absence in the *prog-1*-positive progenitor cell population that mirrored observations of the *piwi-1* stem cell population was found, suggesting that the stem and progenitor cell pools were rapidly depleted following loss of *med14.* In support of this model, widespread apoptosis was evident in *med14(RNAi)* animals by 3fd9 ([Figures 6](#fig6){ref-type="fig"}L--6M′). In contrast, knockdown of *med14* function had no effect on differentiated cells as exemplified by expression of CNS (*pc2*), gut (*porcn*), muscle (*collagen*), pharynx (*laminin*), eye (*ovo*), and protonephridia (*cavii-1*) markers at 3fd12, with the general patterns of expression and organ shapes being normal ([Figures 6](#fig6){ref-type="fig"}N--6Y). These results suggest that loss of *med14* has a specific effect on the stem cell population and that transcription in general is not compromised.

To investigate a more general requirement for Mediator in stem cell maintenance, we performed an RNAi knockdown screen of 11 additional Mediator subunits, allowing analysis of 12 of the 25 conserved proteins ([Figure S2](#app3){ref-type="sec"} and table within). A ventral curling phenotype was observed for five subunits tested: *med7*, *med12*, *med17*, *med19*, and *med27* ([Figures S2](#app3){ref-type="sec"}A--S2F and table within). In all cases, depletion of the *piwi-1*-positive stem cell population was evident by 3fd12 ([Figures S2](#app3){ref-type="sec"}A--[S3](#app3){ref-type="sec"}F′). No phenotypes were observed following knockdown of the remaining six subunits (data not shown). When considered collectively, a stem cell phenotype was apparent following knockdown of a subunit from each Mediator domain.

Med14 Is Required for Maintenance of Progenitor Populations in Zebrafish {#sec2.6}
------------------------------------------------------------------------

We next re-examined the zebrafish *log* mutant phenotype, with a focus on stem/progenitor cells and regeneration. Using RNA ISH, we first assayed expression of the retinal stem cell marker *mz98* ([@bib8]) and found that while present at 2.25 dpf, expression was lost by 3.25 dpf in *log* mutants ([Figures 7](#fig7){ref-type="fig"}A--7D). Analysis of the hematopoietic stem cell marker *cmyb* ([@bib6]) in the ventral trunk/tail region of the embryo revealed a loss of expression in *log* mutants by 3.25 dpf ([Figures 7](#fig7){ref-type="fig"}E--7H). Similarly, the putative gut stem cell marker *lgr4* ([@bib22]) showed a severe reduction in expression in *log* mutants at 3.25 dpf ([Figures 7](#fig7){ref-type="fig"}I and 7J). To assess a possible role for Med14 in vertebrate regeneration, we employed amputation of the zebrafish embryonic tailfin ([@bib32]). Following resection of the tailfin at 2 dpf, we observed no appreciable regrowth of *log* mutant fins by 4 dpf ([Figures 7](#fig7){ref-type="fig"}K and 7L).

We next assessed readouts of stem cell function. As indicated by o-Dianisidine staining, the pronounced expansion of the red blood cell population evident in WT embryos from 48--96 hpf did not occur in *med14* mutants ([Figures 7](#fig7){ref-type="fig"}M--7R). We next examined growth of the zebrafish ventricle from 24--48 hpf, which has recently been shown to include addition of cells from second heart field progenitors ([@bib39]). Cardiomyocyte cell number was significantly reduced in 60 hpf *med14* morphant hearts ([Figures 7](#fig7){ref-type="fig"}S--7U). To test whether the expression of WT *med14* in cardiomyocytes could rescue the *log* heart defect, we generated a cardiomyocyte-specific *cmlc2:med14* transgenic line. Despite forced expression of WT *med14* RNA in mutant hearts well before the onset of phenotypic defects, no rescue was observed ([Figure 7](#fig7){ref-type="fig"}V). Consistent with these results, expression of the second heart field progenitor marker *ltbp3* ([@bib73]) was greatly reduced in *log* mutant embryos at 48 hpf ([Figures 7](#fig7){ref-type="fig"}W and 7X), suggesting that *med14* is required in heart progenitor cells (prior to *cmlc2* expression).

Discussion {#sec3}
==========

In this study, we have shown in two animal models (including one adult one) that the Mediator complex plays a key role in stem cell maintenance. To our knowledge, our planarian work is the first broad in vivo survey of Mediator function in stem cells. Further, our results represent a whole-organism view that helps address controversies in Mediator function in general transcription versus having more specialized functions.

Our results, we believe, provide the first description of the consequences of the complete loss of function of *med14* in metazoa. A zebrafish *med14* mutant was reported as having relatively minor defects in eye development ([@bib16]). However, this mutant (*hi2143*) resulted from an intronic retroviral insertion, and online pictures available show roughly normal development (<http://web.mit.edu/hopkins/group6.html>). As this is a much weaker phenotype than seen in *log* mutants, the insertion allele is likely hypomorphic. A mouse *med14* mutant made from a gene trap ESC line reported no overt phenotypes at day 10.5 ([@bib13]). However, our analysis of this gene trap line by RT-PCR revealed that WT *Med14* transcript was still present, indicating that this allele was not a null (data not shown). In contrast, RNAi-mediated knockdown of *rgr1* (*med14*) in *C. elegans* has been reported to mimic loss of Pol II, which contrasts our findings in zebrafish and planarians ([@bib58]). Of course, it remains possible that the *med14* alleles used in our studies are not true nulls. All three encode C-terminally truncated versions of Med14, with the *m673* and *s231* alleles resembling the original (viable) yeast *rgr1* (*med14*) mutant. This truncation prevented association of Rgr1 with many Mediator Tail components, resulting in a largely "Tail-less" Mediator ([@bib40; @bib53]). In contrast, a yeast *rgr1* null (deletion) allele results in lethality ([@bib53]). As the *m628* allele creates a large truncation of Med14 and further results in pronounced loss of transcript, we are confident that this results in a full loss of function. Recent analysis of Mediator structure has shown that Med14 is a key interface that contacts all three Mediator modules ([@bib66]), with Med14 being essential for activity of a biochemically reconstituted Mediator complex ([@bib9]). As we were unable to examine the full (maternal zygotic) zebrafish *med14* mutant phenotype, the observed onset of *log* phenotypes is likely due to when depletion of maternal protein brings Med14 levels below a threshold level in certain cell types. As discussed below, this may be especially relevant to genes with "superenhancers," which may require a higher level of Mediator in a cell.

Our work suggests that stem and progenitor cells may be especially sensitive to Mediator complex function and that the *log* phenotype is due to loss of stem cells. This will require more extensive study, including cell fate and lineage tracing approaches. Interestingly, our transplantation experiments clearly show that cells lacking Med14 can survive to adulthood and contribute to many tissues. Gene expression analysis in *log* mutants did not reveal effects on stem-cell specific genes; however, analysis of whole embryo transcriptomes is not well suited to detect changes in small populations of cells. While the nature of the stem cell defect in zebrafish *med14* mutants requires further clarification, the effects of Med14 loss on planarian adult stem cell function is more evident. This is associated with a loss of proliferation and increased apoptosis in animals, but not an increase in *prog-1* expression. Our results therefore suggest a model where *piwi-1*-positive stem cells are depleted following *med14* RNAi, perhaps via cell death. This requires further investigation, as does the cellular autonomy (in stem cells versus a niche) of Med14 function.

The role of Mediator in general versus specialized aspects of Pol II-based transcription has been the subject of debate. Work in yeast suggests that core components of Mediator are required for most Pol II-mediated transcription and that Mediator subunits are localized upstream of most promoters ([@bib2; @bib24]). In contrast, Mediator has also been shown to be localized to a very limited fraction (perhaps 3%) of promoter elements ([@bib18]), regulating expression of a low percentage of genes ([@bib72]). Similar to our microarray results, expression of only a few hundred genes is misregulated in yeast *rgr1* (*med14*) CTD deletion mutants ([@bib72]). However, it is also true that not all Mediator subunits are equal: loss of "core" subunits such as Med17 may have more severe effects than loss of other subunits ([@bib24]).

In cultured ESCs and induced pluripotent stem cells, multiple Mediator (and cohesin) complex subunits have been shown to play essential roles in stem cell maintenance ([@bib30]). In vivo, Med1, Med14, Med21, and Cdk8 have been shown to be required in hair follicle stem cells, plant meristem, mouse blastocysts, and tumor cells, respectively ([@bib1; @bib4; @bib44; @bib67]). Our planarian results demonstrate a requirement for Mediator subunits from all structural components (Head, Middle, Tail, and Kinase) in adult stem cells. Specific roles for other "core" components of the transcriptional machinery in stem cells have been described. Alterations in expression of the TBP-associated factors (TAFs) have been associated with pluripotency and skeletal muscle differentiation, and expression of many Mediator subunits is decreased during myotube differentiation ([@bib15; @bib43]).

The global expression of Mediator subunit (and TAF) genes in vivo has not been carefully examined to date. It is possible that distinct Mediator complexes, which contain different combinations of subunits, may have differential function in stem cells versus other contexts.

How may Mediator ultimately affect stem cell maintenance? The ESC genome has been described as existing in a poised state, with enhancers of many developmental genes having a bivalent chromatin status ([@bib5; @bib50]). This may be essential for the coordinated maintenance and differentiation of stem cells in response to the appropriate cues ([@bib38]). It is interesting to note that a variant form of the Pol II complex containing Gdown1 (Pol II(G)) requires Mediator for activator-based Pol II transcription ([@bib25; @bib29]). Interestingly, Pol II(G) is highly enriched at genes with poised Pol II. The Polycomb/PRC2 complex has been shown to inhibit the bivalent poised status of genes in ESCs ([@bib27]). PRC2 and cohesin complexes can physically interact ([@bib59]) and may competitively bind DNA ([@bib14]). A function of Mediator/cohesin may be to prevent association of PRC2 activity with pluripotency-associated genes. Finally, the recent description of stem cell-enriched super-enhancers is of special interest. These atypically large enhancer regions are highly enriched for Mediator (Med1) occupancy, with Mediator being essential for their organization ([@bib42; @bib71]). Enrichment for Mediator occupancy at *Nanog* enhancers that form complex interactions with multiple sites in the genome is similarly associated with pluripotency ([@bib3]). It is therefore tempting to speculate that Mediator is intimately involved with establishing the epigenetic landscape essential for pluripotency and stem cell maintenance. In this context, super-enhancer-regulated genes, which contain high levels of Mediator, may be especially sensitive to Mediator levels and/or complex organization.

Experimental Procedures {#sec4}
=======================

Mutant and Transgenic Zebrafish Lines {#sec4.1}
-------------------------------------

Zebrafish were housed and handled as per Canadian Council on Animal Care and Hospital for Sick Children Laboratory Animal Services guidelines. The *s231* allele of *med14* ([@bib28]), *hsp70:EGFP* ([@bib19]), and *Ola.Actb:Hsa.HRAS-EGFP*^*vu119*^ ([@bib11]) lines have been previously described. *m628* and *m67*3 were acquired from the Zebrafish International Resource Center (ZIRC). We generated *hsp70:med14*, *cryaa:EGFP*^*hsc10*^, and *myl7:med14, cryaa:EGFP* transgenics using standard Tol2 transgenesis ([@bib31]). Full-length zebrafish *med14* coding sequence was subcloned downstream of a *hsp70* ([@bib19]) or *myl7*/*cmlc2* ([@bib26]) promoter between minimal Tol2 transposon arms ([@bib69]) in a pBluescript backbone vector carrying a *cryaa*:*EGFP* cassette ([@bib36]). Heat shock was performed for 30 min in 37°C media. *Tg(myl7:nlsDsRedExpress*^*hsc4*^*)* embryos were used to quantify cardiomyocyte number as previously described ([@bib61]).

Positional Cloning of *log* {#sec4.2}
---------------------------

Mutant embryos collected from incrosses of heterozygous breeding pairs from a *log*^*s231*^/WIK mapcross were screened for recombination at two flanking markers (Z45039 and Z9112). Additional simple sequence length polymorphism (SSLP) markers were designed based on genomic dinucleotide repeats. Recombinant mutant embryos were screened with these markers to further narrow the genomic region. Coding sequence of candidate genes within the region were cloned by RT-PCR and sequenced to uncover mutations in *s231*, *m628*, and *m673* alleles.

Morpholino and mRNA Microinjections, Transplantation {#sec4.3}
----------------------------------------------------

For rescue/overexpression analysis, full-length WT or mutant (*s231*, *m628*, *m673*) *med14* coding sequence was subcloned into pCS2+ vector for in vitro transcription using the mMESSAGE mMACHINE kit (Applied Biosystems) and injected at 300 pg per embryo. A *med14* morpholino targeting the ATG translational start site (5′-CCGAACCGATCTGAACTGGAGCCAT-3′) was purchased from Gene Tools, with 6 ng injected per embryo. For transplantation experiments, donor embryos from a *log*^*m628*^+/−*; Ola.Actb:Hsa.HRAS-EGFP*^*vu119*^ +/− cross were used, with cells transplanted into multiple regions of WT host embryos at 4 hpf. Donor embryos were kept paired with corresponding host embryos to identify *log* mutant donors that were EGFP+'ve.

RNA ISH {#sec4.4}
-------

RNA ISH using DIG-labeled antisense RNA probes was performed as previously described ([@bib48; @bib63]). Fluorescent ISH (FISH) in planarians using the alkaline phosphatase (AP) substrate Fast Blue was performed as previously described ([@bib12]). Probe fragments used are described in [Supplemental Information](#app3){ref-type="sec"}.

Microarray Analysis of Gene Expression {#sec4.5}
--------------------------------------

Two-color microarray experiments were performed by the UHN Microarray Facility using the Zebrafish (v.3) 44 k Gene Expression Microarray Platform (Agilent). cDNA was generated from total RNA isolated from pools of 20 WT or *m628* mutant embryos at 54 hpf, with two biological replicates used. Microarray results were analyzed using Genespring v.11.0.1 (Agilent), with data normalized using Agilent's Spatial Detrending and Lowess normalization. After normalization and averaging, data were filtered such that only probes that were between the 20th and 100th percentile of the distribution of intensities in both samples for either group were kept. Statistical significance for differential expression between sample groups was set at p \< 0.05.

Quantitative Real-Time PCR and RNA Quantification {#sec4.6}
-------------------------------------------------

Reverse transcription reactions were conducted on total RNA extracted from 10 embryos using a SuperScript III Reverse Transcriptase Kit (Invitrogen). Quantitative real-time PCR was performed in triplicate using an Applied Biosystems Real-time PCR system (Life Technologies) with Platinum SYBR Green PCR Master Mix (Invitrogen). For relative quantification of *med14* (SE: CAGAGACTGTGTTCGCATCA, AS: TCAGACAGAACTGCACATTCC), the comparative C~T~ method was used ([@bib57]). Primer pairs for ubiquitously expressed *β-actin* were used as a reference ([@bib62]). Methods for analysis of mean normalized expression ([@bib7]) are described in the [Supplemental Information](#app3){ref-type="sec"}. For mRNA quantification, total RNA was extracted from 3.25 dpf WT and *log* mutant embryos using Trizol. Poly A mRNA was then isolated from 0.1 mg of total RNA using a QIAGEN Oligotex mRNA mini kit (QIAGEN), followed by quantification using a Nano-Drop spectrophotometer (Thermo Scientific).

Apoptosis, Proliferation, and Cell Cycle Assays {#sec4.7}
-----------------------------------------------

Apoptotic cells were detected in zebrafish embryos using an In Situ Cell Death Detection Kit-AP (Roche). For cell proliferation experiments, embryos were incubated on ice for 10 min in 10-mM bromodeoxyuridine (BrdU) (Sigma) in 15% DMSO. Mouse anti-BrdU (BD Biosciences) primary and Alexa Fluor 568 anti-mouse secondary (Invitrogen) antibodies were used. Whole-mount terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining was carried out in planarians as previously described ([@bib49]).

Flow Cytometry Analysis {#sec4.8}
-----------------------

Single-cell suspensions were fixed in ethanol and stained with propidium iodide (0.1 mg/ml in Hank's balanced salt solution \[HBSS\] with 0.6% NP40 and 2mg/ml RNase A) for 30 min at room temperature. A FACSLSRII flow cytometer (BD Biosciences) was used, with data analyzed using FlowJo software (Tree Star). Three samples were run for both conditions (wild-type and mutant) at each time point (54 and 78 hpf).

Immunohistochemistry {#sec4.9}
--------------------

A 1:100 dilution of rhodamine phalloidin (Life Technologies) was used in zebrafish. Immunostaining with anti-phosphohistone H3 (H3ser10p, 1:500 dilution; Millipore) with a 1:200 dilution of a goat anti-rabbit IgG HRP secondary antibody (Jackson ImmunoResearch) to label mitotic cells in planarians and monoclonal mouse anti-PIWI (1:1000, gift from Jochen Rink) with a 1:300 dilution of a goat anti-mouse HRP secondary antibody (Jackson ImmunoResearch) to label stem cells was performed as previously reported ([@bib45]). For detection of the presence of hemoglobin, PFA-fixed zebrafish embryos were stained in the dark for 10 min in PBS containing o-Dianisidine dihydrochloride (0.6 mg/ml; Sigma), sodium acetate (0.01 M, pH 4.5), H~2~O~2~ (0.65%), and ethanol (40%).

Planarian RNAi and Homeostasis/Regeneration Assays {#sec4.10}
--------------------------------------------------

The asexual clonal line CIW4 of *S. mediterranea* was maintained as previously described ([@bib54]). For production of dsRNA for RNAi experiments, a pRT4P vector containing either full-length (*med14*) or partial (remaining Mediator subunits) cDNA was expressed in a HT115 bacterial strain as previously reported ([@bib55]). RNAi food was made by mixing a pellet of dsRNA-expressing bacteria from 30 ml of culture (OD600 of 0.8) with 300 μl of 70% liver paste. For both homeostasis and regeneration assays, RNAi food was fed to worms every 3 days for three feedings. Animals were amputated into three equal pieces 3 days after the last feeding (3fd3). For zebrafish regeneration assays, fin primordia of anesthetized embryos were cut immediately posterior to the notochord at 48 hpf using a number 17 (square ended) scalpel blade as previously described ([@bib32]).
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![Characterization of the *log* Mutant Phenotype\
(A--I) Expression of cardiac markers in (WT) and *log* mutant (MUT) embryos. While at 1.0 dpf the linear heart tube (black arrowhead) was apparent in all embryos ("WT/MUT"), at 2.25 dpf *log* mutant hearts were unlooped, with the ventricle directly above the atrium (yellow and red arrowheads, respectively).\
(J--M) At 4.0 dpf, semicircular canals in the otic vesicles (black arrow heads in J and K) and elongation of the pectoral fins (black arrowheads in L and M) were absent in mutant embryos.\
(N) Change in head/trunk angle over time in WT and mutant embryos (10 WT and 20 mutants measured per time point).\
See also [Figure S1](#app3){ref-type="sec"}.](gr1){#fig1}

![*Logelei* Results from a Mutation in *med14*\
(A) Recombination frequency mapping results. Screening of 1,800 map-cross mutant embryos with markers Z45039 and Z9112 revealed 16 and 39 flanking recombinant embryos, respectively. The zero-recombinant region (light green, contained in two bacterial artificial chromosomes \[BACs\]) was refined with additional markers. Sequencing of *med14* revealed a base pair substitution (arrow) leading to a premature stop codon (^∗^) in each of the three *log* alleles.\
(B--E′′′) Lateral and dorsal views of the otic vesicle and pectoral fin of 3.5 dpf WT (B--B′′′), *log* mutant (C--C′′′), *med14* morpholino-injected (D--D′′′), and *log* mutant injected with *med14* RNA (E--E′′′) embryos.](gr2){#fig2}

![Expression and Timing Requirement of *med14* for Development\
(A) Worsening of the *log* mutant phenotype by injection of morpholino (MO) targeting *med14* (red arrowhead denotes somite defect).\
(A′ and A′′) Somite structure of 3.5 dpf rhodamine phalloidin (RhPh) stained WT and MO-injected mutant embryos. Defects in muscle fiber patterns of mutant embryos injected with MO are shown (yellow arrowheads).\
(B--D) RNA ISH analysis shows that *med14* is broadly expressed at the one- and two-cell stage and at 12 hpf ("WT/MUT" denotes unknown genotype). At 24 hpf, broad *med14* expression is undetectable in zygotic *med14* mutants.\
(E--K) Temporal rescue of the *log* mutant phenotype using *Tg(hsp70:med14, α-crystallin:EGFP)*, with initial heat shock performed at the specified time, and then every 12 hr following until 5 dpf. Scale bars, 0.5 mm.](gr3){#fig3}

![Transcription Is Not Largely Affected in *log* (*med14*) Mutants\
(A--D) Expression of *opn1sw1*, initiated by 2.5 dpf in WT embryos, reaches WT levels in *log* mutant embryos by 4.0 dpf.\
(E) *T*g(*hsp70:EGFP) log* mutant embryos heat shocked at 3.5 dpf show robust GFP signal.\
(F--H′) *log* mutant cells transplanted into WT hosts (traced using a *β-actin:EGFP* transgene) are evident in 15 dpf hosts (including in the semicircular canals, yellow arrowhead in F) and survive until 2 ypf (years post-fertilization, yellow arrowheads).\
(I) Summary of results of microarray analysis on cDNA from 2.25 dpf WT versus *log* mutant embryos.\
(J) Quantification of mRNA per 0.1mg total RNA at 3.25 dpf from WT and *log* mutant embryos.\
(K) Normalized qPCR values for *med14* expression in mutant relative to WT control embryos (^∗^p \< 0.05 using the one-tailed unpaired Student's t test).\
(L) Mean normalized expression (MNE) of *β-actin* in WT and MUT embryos at 2.25 dpf calculated using a universal reference approach. No significant difference (p = 0.63) was observed between WT (0.107 ± 0.00380) and *log* MUT (0.123 ± 0.0297) samples (n = 3) by one-tailed unpaired Student's t test. For (J)--(L), three biological replicates of 450 (J) or 10 (K and L) embryos were used.](gr4){#fig4}

![*Smed-med14* Is Required for Tissue Homeostasis and Regeneration in Planarians\
(A--F) *med14(RNAi)* animals show defects in homeostasis, with head regression (yellow arrowheads) and ventral curling apparent in 100% of cases by 3fd10.\
(G and H) By 3fd12--15, head and tail regression (yellow and red arrowheads) and the beginnings of lysis are apparent in 100% of *med14(RNAi)* animals, similar to what is observed following irradiation-mediated depletion of the stem cell pool.\
(I--L) In trunk fragments that are regenerating a head (yellow arrowhead) and a tail (red arrowhead), no regeneration is observed by 7 dpa in *med14(RNAi)* animals.\
Scale bars, 100 μm.](gr5){#fig5}

![*Smed-med14* Is Necessary for the Maintenance of Adult Stem Cells\
(A) ISH for *med14* in wild-type intact animals showing ubiquitous staining.\
(A′) A stem cell like expression pattern is evident with reduced staining.\
(A′′ and A′′′) Confocal image at 25× magnification of *med14* fluorescent RNA ISH (red) and PIWI antibody staining (green) in the planarian head (white dashed box in A′) and tail (black dashed box in A′) respectively. The boxed area in each is enlarged for clarification. *med14* is expression in, but not limited to, the stem cell population.\
(B--C′′′) ISH analysis using a stem cell specific riboprobe (*piwi-1*) during a time course of *med14(RNAi)*. By 3fd12, the stem cell population is largely absent in *med14(RNAi)* animals. The remaining *piwi-1+* cells at 3fd12 (C′′′) may represent primordial germ cells (red arrowheads in M).\
(D--E′) Loss of proliferative phosphorylated histone H3 (H3P) +'ve cells in *med14(RNAi)* animals by 3fd9 (E′).\
(F--I) Expression of S-phase markers *h2b* and *pcna* in WT and *med14* RNAi animals at 3fd12.\
(J--K′) By 3fd3, the progenitor cell population in *med14(RNAi)* animals (marked by *prog-1* expression) is reduced compared with controls and completely absent by 3fd12.\
(L--M′) Increased cell death by 3fd9 as observed by whole-mount TUNEL analysis in *med14(RNAi)* animals.\
(N--Y) Normal expression of markers of differentiated cell types in *med14(RNAi)* animals as evident for the nervous system (*pc2*), gut (*porcn*), muscle (*collagen*), pharynx (*laminin*), eyes (*ovo*), and protonephridia (*cavii-1*). Head regression is evident in some treated worms (black arrow heads in O and Q). Eye progenitors (red arrow head in V) are not observed in *med14(RNAi)* animals despite *ovo* expression in the eye spots (black arrow heads in V and W).\
Scale bars, 100 μm. See also [Figure S2](#app3){ref-type="sec"}.](gr6){#fig6}

![A Conserved Requirement for *med14* in the Maintenance of Stem Cell Populations\
(A--D) Expression of retinal stem cell marker *mz98* (arrowhead) is present, but reduced in *log* mutants at 2.25 dpf, and absent at 3.25 dpf.\
(E--H) Expression of the hematopoietic stem cell marker *cmyb* is initiated in 2.25 dpf *log* mutant embryos (arrowhead), but largely absent by 3.25 dpf.\
(I and J) Expression of the putative gut stem cell marker *lgr4* is not observed in 3.25 dpf *log* mutant embryos (arrowhead, note expression in WT).\
(K and L) Robust tail fin regeneration in WT as compared with *log* mutant embryos at 4 dpf following amputation (at area of dotted line) at 2 dpf.\
(M--R) o-Dianisidane staining of red blood cells in trunks of WT and *log* mutant embryos. Scale bars, 0.5 mm.\
(S and T) Confocal projections of 2.5 dpf *Tg(cmcl2:nlsDsRedExpress)* WT and *log* morphant hearts.\
(U) Quantification of myocardial cell number in WT and morphant hearts shows a significant decrease in morphants (p = 0.0017, n = 6 for both conditions).\
(V) Cardiac edema and heart defects remain in 3.5 dpf *Tg (cmlc2:med14, α-crystallin:EGFP) log* mutant embryos.\
(W and X) Expression of the second heart field marker *ltbp3* in the arterial pole of the heart (arrowhead) is reduced in *log* mutants at 48 hpf.](gr7){#fig7}
